Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
125.78
Dollar change
+0.55
Percentage change
0.44
%
IndexDJIA, S&P 500 P/E951.44 EPS (ttm)0.13 Insider Own0.15% Shs Outstand2.53B Perf Week0.03%
Market Cap318.56B Forward P/E12.82 EPS next Y9.81 Insider Trans-10.71% Shs Float2.53B Perf Month1.56%
Income365.00M PEG14.12 EPS next Q1.90 Inst Own78.68% Short Float0.77% Perf Quarter5.80%
Sales59.87B P/S5.32 EPS this Y466.79% Inst Trans0.64% Short Ratio2.36 Perf Half Y23.33%
Book/sh14.84 P/B8.47 EPS next Y14.63% ROA0.34% Short Interest19.59M Perf Year10.21%
Cash/sh2.83 P/C44.48 EPS next 5Y67.38% ROE0.87% 52W Range99.14 - 133.10 Perf YTD15.37%
Dividend Est.3.23 (2.57%) P/FCF34.84 EPS past 5Y-42.70% ROI0.51% 52W High-5.50% Beta0.41
Dividend TTM3.00 (2.39%) Quick Ratio1.00 Sales past 5Y7.72% Gross Margin70.37% 52W Low26.87% ATR (14)1.94
Dividend Ex-DateMar 14, 2024 Current Ratio1.25 EPS Y/Y TTM-97.48% Oper. Margin5.08% RSI (14)48.59 Volatility1.19% 1.42%
Employees72000 Debt/Eq0.97 Sales Y/Y TTM2.39% Profit Margin0.61% Recom1.55 Target Price138.26
Option/ShortYes / Yes LT Debt/Eq0.92 EPS Q/Q-140.87% Payout2065.60% Rel Volume1.01 Prev Close125.23
Sales Surprise0.97% EPS Surprise127.65% Sales Q/Q13.82% EarningsApr 25 BMO Avg Volume8.30M Price125.78
SMA20-1.06% SMA50-0.22% SMA20011.73% Trades Volume8,385,686 Change0.44%
Date Action Analyst Rating Change Price Target Change
Mar-11-24Downgrade Societe Generale Hold → Sell $104
Jan-04-24Upgrade TD Cowen Market Perform → Outperform $125 → $135
Nov-09-23Initiated Deutsche Bank Buy $115
Oct-27-23Upgrade BMO Capital Markets Market Perform → Outperform $132
Oct-20-23Upgrade UBS Neutral → Buy $117 → $122
Jul-14-23Initiated HSBC Securities Hold $123
Apr-13-23Upgrade Citigroup Neutral → Buy $105 → $130
Mar-28-23Downgrade Societe Generale Buy → Hold
Mar-13-23Downgrade Wells Fargo Overweight → Equal Weight $120 → $115
Mar-06-23Initiated Jefferies Buy $125
Today 10:49AM
Apr-19-24 07:04AM
Apr-18-24 04:27PM
10:01AM
Apr-17-24 05:50PM
07:48AM Loading…
Apr-15-24 07:48AM
Apr-12-24 06:40AM
Apr-11-24 05:50PM
Apr-08-24 11:38PM
02:00PM
Apr-07-24 02:00PM
Apr-06-24 08:47PM
Apr-05-24 05:45PM
05:33AM
Apr-04-24 07:38AM
06:45AM Loading…
06:45AM
05:36AM
Apr-03-24 05:50PM
08:00AM
Apr-01-24 09:50AM
06:45AM
Mar-29-24 10:51AM
Mar-28-24 05:50PM
09:15AM
06:45AM
Mar-27-24 04:36PM
04:00PM
02:58PM
12:20PM
11:54AM
10:58AM Loading…
10:58AM
10:26AM
10:10AM
09:53AM
09:00AM
08:50AM
08:39AM
07:36AM
07:36AM
Mar-26-24 06:21PM
05:07PM
01:12PM
09:30AM
05:15AM
Mar-24-24 09:54AM
Mar-22-24 05:45PM
10:26AM
Mar-21-24 03:00PM
10:25AM
06:45AM
Mar-20-24 05:50PM
Mar-19-24 09:00AM
Mar-15-24 04:23PM
12:17PM
06:45AM
Mar-14-24 07:01PM
05:45PM
Mar-13-24 05:50PM
09:03AM
09:00AM
07:01AM
03:00AM
02:45AM
Mar-11-24 04:53PM
08:15AM
Mar-09-24 12:58PM
10:06AM
Mar-06-24 10:25AM
Mar-05-24 08:30AM
06:45AM
02:56AM
Mar-04-24 08:28PM
06:45AM
Mar-02-24 10:42AM
Mar-01-24 06:14AM
Feb-28-24 06:46PM
10:17AM
09:00AM
Feb-27-24 06:45AM
Feb-26-24 01:19PM
11:29AM
Feb-23-24 05:21PM
06:20AM
05:43AM
Feb-22-24 11:22AM
Feb-20-24 06:45AM
Feb-18-24 04:33PM
Feb-16-24 08:30AM
03:10AM
Feb-15-24 11:37PM
08:45AM
Feb-14-24 10:00AM
Feb-13-24 02:16PM
11:45AM
Feb-12-24 07:05AM
Feb-11-24 08:44AM
Feb-09-24 04:32PM
01:03PM
Feb-08-24 07:00AM
Feb-07-24 12:13PM
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Merck & Co., Inc.10% OwnerMar 11 '24Buy23.0021,397,205492,135,7151,000Mar 11 03:27 PM
Davis Robert MChairman, CEO & PresidentFeb 14 '24Option Exercise73.7385,0216,268,598433,348Feb 15 04:01 PM
Litchfield CarolineEVP & CFOFeb 14 '24Option Exercise58.0838,2912,223,94189,199Feb 15 04:03 PM
Davis Robert MChairman, CEO & PresidentFeb 14 '24Sale125.4085,02110,661,574348,327Feb 15 04:01 PM
Litchfield CarolineEVP & CFOFeb 14 '24Sale125.5038,2914,805,52050,908Feb 15 04:03 PM
Davis Robert MChairman, CEO & PresidentFeb 13 '24Option Exercise74.18150,00011,127,160498,327Feb 15 04:01 PM
Davis Robert MChairman, CEO & PresidentFeb 13 '24Sale125.85150,00018,877,424348,327Feb 15 04:01 PM
Romanelli JosephPresident, Human Health Int?lFeb 13 '24Sale124.891,000124,88819,569Feb 14 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09 '24Option Exercise62.0714,702912,55360,944Feb 12 04:03 PM
Li Dean YExecutive VP & President, MRLFeb 09 '24Sale125.5014,7021,845,08346,242Feb 12 04:03 PM
Williams David MichaelEVP,Chief Info&Digital OfficerFeb 07 '24Sale127.571,451185,10819,812Feb 08 04:04 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02 '24Option Exercise73.6532,9942,430,15974,313Feb 02 04:07 PM
Zachary JenniferEVP, General CounselFeb 02 '24Option Exercise87.1019,4171,691,22178,557Feb 02 04:05 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02 '24Option Exercise78.8020,9371,649,90642,286Feb 05 04:01 PM
MIZELL STEVENEVP, Chief HR OfficerFeb 02 '24Sale126.6550,6946,420,34923,619Feb 02 04:07 PM
Zachary JenniferEVP, General CounselFeb 02 '24Sale126.9749,4996,284,77929,058Feb 02 04:05 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketFeb 02 '24Sale127.1718,9592,411,11123,327Feb 05 04:01 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketNov 09 '23Sale102.382,081213,06118,191Nov 13 07:36 AM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthNov 08 '23Sale105.0343,8234,602,668111,764Nov 09 09:04 AM
Oosthuizen Johannes JacobusPresident, U.S. MarketOct 30 '23Option Exercise102.8291594,08020,723Oct 31 11:08 AM
MIZELL STEVENEVP, Chief HR OfficerAug 14 '23Sale109.014,250463,29222,935Aug 15 04:08 PM
Guindo ChirfiChief Marketing OfficerAug 03 '23Option Exercise105.7036,9013,900,43638,342Aug 04 04:17 PM
MIZELL STEVENEVP, Chief HR OfficerAug 03 '23Sale105.494,500474,70127,185Aug 04 04:06 PM
Romanelli JosephPresident, Human Health Int?lAug 02 '23Sale107.37596,3350Aug 03 04:08 PM
Romanelli JosephPresident, Human Health Int?lAug 02 '23Sale107.37303,22120,569Aug 03 04:08 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04 '23Option Exercise65.2416,8241,097,55261,585May 05 04:54 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketMay 04 '23Option Exercise118.22907107,22620,207May 05 05:09 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 04 '23Option Exercise118.22885104,62519,476May 05 05:06 PM
LeCointe-Cephas LisaSVP Chief Ethics & Com OfficerMay 04 '23Option Exercise118.2281396,1135,421May 05 05:01 PM
Zachary JenniferEVP, General CounselMay 04 '23Sale117.5919,1412,250,83435,128May 05 05:13 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04 '23Sale117.5315,8751,865,84345,710May 05 04:54 PM
MIZELL STEVENEVP, Chief HR OfficerMay 03 '23Option Exercise75.5552,0003,928,54073,085May 05 05:19 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 03 '23Option Exercise117.8980394,66645,363May 05 04:54 PM
LeCointe-Cephas LisaSVP Chief Ethics & Com OfficerMay 03 '23Option Exercise117.8968981,2264,844May 05 05:01 PM
MIZELL STEVENEVP, Chief HR OfficerMay 03 '23Sale119.0153,4006,355,05631,685May 05 05:19 PM
Williams David MichaelEVP,Chief Info&Digital OfficerMay 02 '23Option Exercise56.046,035338,20118,568May 03 04:29 PM
Williams David MichaelEVP,Chief Info&Digital OfficerMay 02 '23Sale116.827,509877,22211,059May 03 04:29 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 01 '23Option Exercise56.0475,4364,227,433229,929May 02 11:37 AM
Li Dean YExecutive VP & President, MRLMay 01 '23Option Exercise115.471,062122,62920,995May 03 04:10 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 01 '23Option Exercise115.47930107,38744,879May 03 04:24 PM
Oosthuizen Johannes JacobusPresident, U.S. MarketMay 01 '23Option Exercise115.4786699,99719,727May 03 03:54 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 01 '23Option Exercise115.4786699,99718,901May 03 03:00 PM
Litchfield CarolineEVP & CFOMay 01 '23Option Exercise115.4786699,99732,118May 03 04:07 PM
LeCointe-Cephas LisaSVP Chief Ethics & Com OfficerMay 01 '23Option Exercise115.4764374,2474,376May 03 03:11 PM
Williams David MichaelEVP,Chief Info&Digital OfficerMay 01 '23Option Exercise115.4757766,62612,731May 03 04:29 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 01 '23Sale116.0375,4368,752,749154,493May 02 11:37 AM
Davis Robert MChairman, CEO & PresidentApr 28 '23Option Exercise56.04143,3298,032,157415,146Apr 28 05:15 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthApr 28 '23Option Exercise62.0766,1634,106,737220,656May 02 11:37 AM
Davis Robert MChairman, CEO & PresidentApr 28 '23Sale114.93143,32916,472,845271,817Apr 28 05:15 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthApr 28 '23Sale115.0066,1637,608,844154,493May 02 11:37 AM
Romanelli JosephPresident, Human Health Int?lApr 26 '23Buy113.68334120,599Jun 30 04:04 PM